Main menu

Core Therapeutic Areas

Core Therapeutic Areas

To strengthen our scientific core, we are investing in areas where we see the greatest opportunity and where we believe we can deliver the best value. We also forge novel partnerships that allow us to access the best science.

While we continue to pursue and invest in additional therapies in early and late stages of clinical development (see Worldwide Research & Development (WRD) and Biopharmaceuticals pages), the following are Pfizer's priority R&D therapeutic areas:

NOTE: For opportunities that fall into the pre-clinical proof of concept space, generally before phase 2b of development, visit the WRD links below. For post-clinical proof of concept, generally post phase 2a of development, visit the biopharmaceutical business units.

Cardiovascular and Metabolic Disease

Immunology

Inflammation

Neuroscience

Oncology

Vaccines

Pain and Sensory

Connect With Us

callout-placeholder

Reach out. We want to hear from you.

Submit Your Opportunity

callout-placeholder

Send us your innovative ideas today.